Our reagent portfolio offers flexibility of vial sizes and provides superb on-board stability across our Hemostasis analyzers.

In 2010, Sysmex Corporation aquired HYPHEN BioMed enabling us to provide a comprehensive line of reagents to complement our existing Siemens hemostasis reagents portfolio. HYPHEN BioMed is a scientific company with experience in the field of thrombosis, hemostasis and auto-immunity, producing a full line of diagnostic and research reagents, distributed worldwide.